We explored a unique case of recurrent fainting after hysteroscopy, ultimately revealed as cerebral venous sinus thrombosis (CVST). This rare condition can mimic symptoms of more common complications like TURP syndrome, making diagnosis tricky.
Our patient, a 33-year-old woman, experienced multiple episodes of syncope and nausea shortly after her surgery. Administration of anticoagulants and folic acid, among other treatments, led to recovery. This case highlights the need for awareness of underlying vascular issues when typical surgery complications are ruled out.
Read More
8
Pediatric blood clot management insights
CENTRAL RETINAL VEIN OCCLUSION IN 12-YEAR-OLD GIRL WITH METHYLENETETRAHYDROFOLATE REDUCTASE MUTATION: A CASE REPORT AND REVIEW OF THE LITERATURE.
We examined the case of a healthy 12-year-old girl who experienced a central retinal vein occlusion. This incident was particularly notable because she later developed retinal neovascularization at the age of 24. This timing marks the longest gap reported between such a pediatric event and subsequent complications.
Throughout the evaluation, we noted that the girl's family history was not significant for similar conditions. However, laboratory tests flagged a mildly elevated homocysteine level and uncovered a homozygous C677T mutation in methylenetetrahydrofolate reductase. As a proactive measure, we initiated folate supplementation to possibly mitigate future thrombotic risks.
So far, this approach has shown promise, as the patient has not experienced further ocular or systemic clotting issues. Our findings suggest that folate supplementation may play a beneficial role in managing elevated homocysteine levels, which are associated with blood clotting complications.
This case highlights the importance of a thorough systemic workup and the necessity for long-term follow-up in pediatric patients with central retinal vein occlusion. By taking measures like folate supplementation, we aim to prevent serious complications such as intraocular hemorrhage and neovascular glaucoma.
Read More
7
Folic acid may reduce thrombus risk
Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study.
We investigated how folic acid supplementation affects blood clots in patients with end-stage kidney disease (ESKD) undergoing hemodialysis. Our research used patient data from the Chang Gung Medical Foundation and compared daily versus weekly folic acid dosages.
Interestingly, patients taking daily folic acid showed a lower rate of arteriovenous access thrombosis compared to those on weekly supplements. However, both groups had similar rates of other serious cardiovascular events, suggesting that while daily supplementation may help with thrombosis, it does not significantly impact overall cardiovascular health.
Read More
Most Useful Reviews
9
Lowered homocysteine level
27 people found this helpful
Understanding my homocysteine level is crucial as I plan my pregnancy. After discovering it was high, I switched to methyl folate due to allergies with regular folic acid. Within a month, my levels decreased significantly, and I felt more energetic with clearer thoughts—definitely effective.
Read More
9
Monitored effectiveness
1 people found this helpful
The correct form of methyl folate raised my B9 levels and reduced homocysteine alongside B12. I plan to continue taking it while monitoring my blood tests.
Read More
9
Thins blood well
1 people found this helpful
The best form of folic acid is as folates. It is especially beneficial for those with a blood clot condition. I am planning a pregnancy and have thrombophilia; my doctor recommended this particular form as it aids in thinning the blood effectively.
The Impact of the Dietary Intake of Vitamin B12, Folic Acid, and Vitamin D3 on Homocysteine Levels and the Health-Related Quality of Life of Levodopa-Treated Patients with Parkinson's Disease-A Pilot Study in Romania.
We conducted a multi-center trial in Romania to explore how vitamin B12, folic acid, and vitamin D3 supplements could help lower homocysteine levels in Parkinson's disease patients on levodopa treatment.
Over six months, we observed that participants who took these supplements experienced a significant reduction in homocysteine levels and an improvement in their overall quality of life.
The findings suggest that nutritional support can play a vital role in managing Parkinson's disease, potentially reducing risks associated with elevated homocysteine, such as blood clots and other complications.
Read More
8
Cerebral venous sinus thrombosis case
Recurrent syncope after hysteroscopy finally diagnosed as cerebral venous sinus thrombosis: a case report.
We explored a unique case of recurrent fainting after hysteroscopy, ultimately revealed as cerebral venous sinus thrombosis (CVST). This rare condition can mimic symptoms of more common complications like TURP syndrome, making diagnosis tricky.
Our patient, a 33-year-old woman, experienced multiple episodes of syncope and nausea shortly after her surgery. Administration of anticoagulants and folic acid, among other treatments, led to recovery. This case highlights the need for awareness of underlying vascular issues when typical surgery complications are ruled out.
Read More
8
MTHFR mutation linked to thrombosis
Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report.
We examined a unique case of cerebral venous thrombosis in a 14-year-old girl, associated with hyperhomocysteinemia and a rare mutation at the MTHFR locus. The patient displayed symptoms like headaches and nausea, with significantly elevated homocysteine levels.
After receiving a combination of anticoagulation therapy and supplementation with folate, B12, and B6, her condition improved remarkably over a month, reducing intracranial pressure and alleviating symptoms. This case emphasizes the importance of such genetic analysis in similar thrombotic cases.
We explored how folic acid (FA) affects blood clotting in a study that examined the impact of carbon black (CB) on mice. Over 28 days, mice exposed to CB showed increased blood clotting due to changes in spleen activity and elevated platelet counts.
Interestingly, lower levels of folic acid were noted after CB exposure. However, administering folic acid helped restore normal blood coagulation levels by inhibiting certain inflammatory pathways. Despite these findings, it’s important to state that this study primarily exposes potential mechanisms rather than confirming definitive benefits of folic acid for humans.
Read More
8
Pediatric blood clot management insights
CENTRAL RETINAL VEIN OCCLUSION IN 12-YEAR-OLD GIRL WITH METHYLENETETRAHYDROFOLATE REDUCTASE MUTATION: A CASE REPORT AND REVIEW OF THE LITERATURE.
We examined the case of a healthy 12-year-old girl who experienced a central retinal vein occlusion. This incident was particularly notable because she later developed retinal neovascularization at the age of 24. This timing marks the longest gap reported between such a pediatric event and subsequent complications.
Throughout the evaluation, we noted that the girl's family history was not significant for similar conditions. However, laboratory tests flagged a mildly elevated homocysteine level and uncovered a homozygous C677T mutation in methylenetetrahydrofolate reductase. As a proactive measure, we initiated folate supplementation to possibly mitigate future thrombotic risks.
So far, this approach has shown promise, as the patient has not experienced further ocular or systemic clotting issues. Our findings suggest that folate supplementation may play a beneficial role in managing elevated homocysteine levels, which are associated with blood clotting complications.
This case highlights the importance of a thorough systemic workup and the necessity for long-term follow-up in pediatric patients with central retinal vein occlusion. By taking measures like folate supplementation, we aim to prevent serious complications such as intraocular hemorrhage and neovascular glaucoma.
Understanding my homocysteine level is crucial as I plan my pregnancy. After discovering it was high, I switched to methyl folate due to allergies with regular folic acid. Within a month, my levels decreased significantly, and I felt more energetic with clearer thoughts—definitely effective.
Read More
9
Monitored effectiveness
1 people found this helpful
The correct form of methyl folate raised my B9 levels and reduced homocysteine alongside B12. I plan to continue taking it while monitoring my blood tests.
Read More
9
Thins blood well
1 people found this helpful
The best form of folic acid is as folates. It is especially beneficial for those with a blood clot condition. I am planning a pregnancy and have thrombophilia; my doctor recommended this particular form as it aids in thinning the blood effectively.
Read More
7.5
Decreased homocysteine
30 people found this helpful
Folic acid in the form of methyl folate is better absorbed, leading to decreased homocysteine in my blood. I take it in preparation for pregnancy, as it supports my nervous system and provides energy. The taste is neutral, and the capsule size is convenient.
Read More
7
Improved blood levels
2 people found this helpful
This product effectively raised my vitamin B9 levels as part of my anaemia treatment.
A blood clot is a mass of blood that changes from a liquid to a gel, effectively forming a plug that can stop bleeding. This natural process, known as coagulation, is critical for preventing excessive blood loss when you sustain an injury. Blood clots can occur in various areas of the body, typically at the site of a wound, but they can also form within blood vessels without an obvious injury, which may lead to serious health complications.
While blood clots are essential for healing, they can pose significant health risks if they form inappropriately. For example, a deep vein thrombosis (DVT) occurs when a clot forms in a deep vein, usually in the legs, and can travel to the lungs, causing a life-threatening condition called a pulmonary embolism. Risk factors for blood clots include prolonged immobility, certain medical conditions, and the use of specific medications, among others. It’s important to recognize the symptoms of abnormal clotting, such as swelling, pain, and redness in the affected area, and seek medical attention if they occur.
Folic acid, also known as vitamin B9, is a water-soluble vitamin that plays a crucial role in many bodily functions, particularly in the synthesis of DNA and RNA. It is essential for cell division and is especially important during periods of rapid growth, such as during pregnancy and infancy. The body cannot produce folic acid on its own, which is why it must be obtained from dietary sources or supplements. Commonly found in leafy green vegetables, legumes, seeds, and fortified foods, folic acid is vital for preventing neural tube defects in developing fetuses and is often recommended for women of childbearing age.
In addition to its key role in pregnancy, folic acid contributes to the production of red blood cells and can help reduce the risk of certain types of anemia. Research has also suggested that adequate folic acid levels may be associated with lowered risk of heart disease and other health issues. Most health organizations recommend a daily intake of 400 micrograms for adults, with higher amounts suggested for pregnant women. Incorporating folate-rich foods into your diet, or considering supplementation, can help ensure you meet your folic acid needs.
Folic acid, a B vitamin, plays a crucial role in the synthesis of DNA and the division of cells, and it’s particularly important for pregnant women. Research indicates that folic acid may have a beneficial effect on cardiovascular health, which can indirectly relate to blood clotting. Adequate levels of folic acid can help lower homocysteine levels in the blood, an amino acid that at high levels is associated with an increased risk of blood clots and cardiovascular issues.
However, it’s essential to clarify that while maintaining healthy levels of folic acid can contribute to overall vascular health, it is not a direct treatment for existing blood clots. If you have concerns about blood clotting or related disorders, it's important to consult with a healthcare professional. They can provide personalized advice and treatment options based on your specific health needs.
Users report varying timelines for seeing results when taking methyl folate for blood clot concerns and elevated homocysteine levels. Many individuals notice a decrease in homocysteine levels and an increase in energy within a month of use. For example, one user who switched to methyl folate due to allergies with regular folic acid saw significant improvements in their levels in just under 30 days(Read Review). Another user stated that after a tailored dosage and consultation with experts, they began to see significant decreases in their levels quickly(Read Review).
In addition to the blood level improvements, users have reported other positive changes related to their condition, such as improved overall wellbeing and enhanced blood vessel conditions. One individual noted a notable difference in their painful leg episodes after incorporating methyl folate into their regimen, confirming its effectiveness in managing symptoms related to their condition(Read Review). Overall, while the speed of results can depend on individual circumstances, many report seeing improvements within a few weeks of starting the supplementation.
Scientific research suggests that certain supplements, particularly folic acid and vitamin B12, may play a role in reducing the risk of blood clots, particularly through their relationship with homocysteine levels. Elevated homocysteine is a known risk factor for thrombosis, and studies indicate that folic acid supplementation can help lower these elevated levels, potentially mitigating the risks associated with blood clots. For instance, in patients with end-stage kidney disease, daily folic acid supplementation was associated with a lower rate of arteriovenous access thrombosis compared to those receiving it weekly [5]. Additionally, a case study highlighted that supplementation with folate, B12, and B6 significantly improved outcomes in a patient with cerebral venous thrombosis related to high homocysteine levels [3].
However, it is important to note that while these findings are promising, not all research definitively supports the effectiveness of these supplements on blood clotting. For example, a comprehensive study involving patients with coronary artery disease did not find significant changes in blood clot functionality after folate treatment [10]. Thus, while supplements like folic acid and vitamin B12 may contribute positively to managing blood clot risks—especially in cases of hyperhomocysteinemia—their direct effects on clot formation and overall cardiovascular health require further elucidation. As always, it’s advisable to consult healthcare providers before starting any supplementation, particularly for individuals at risk of blood clotting disorders.
Based on user reviews, many individuals have reported significant improvements in their symptoms after incorporating methyl folate into their health regimens. A common theme among users is the notable decrease in homocysteine levels; one user observed a substantial drop within a month and experienced increased energy and mental clarity during that time (Read Review). Another shared that after customizing their dosage, they saw quick reductions in their levels, further supporting the efficacy of methyl folate for those struggling with absorption issues or specific health conditions (Read Review).
Moreover, users noted other positive outcomes such as enhanced blood vessel health and alleviation of pain associated with conditions like thrombophilia. One individual mentioned a complete disappearance of painful leg symptoms after starting methyl folate, indicating its potential impact on vascular discomfort (Read Review). These anecdotal experiences highlight the diverse benefits users have experienced, though individual results may vary based on health status, dosage, and other personal factors.
Users have reported various insights regarding the combination of methyl folate with other supplements for managing blood clot issues. Several reviewers emphasized the importance of pairing methyl folate with vitamin B12 to enhance its effectiveness. For example, one user noted that after recovering from Covid, they felt safer using methyl folate, especially since those with genetic mutations in the folate cycle may require B12 alongside it for optimal results (Read Review).
Additionally, users have also indicated that combining methyl folate with other supplements, such as niacin, could further improve blood vessel conditions and overall health. One reviewer shared their success when they combined methyl folate with niacin, leading to improved blood fluidity and addressing their genetic predispositions while preparing for pregnancy (Read Review). Overall, the anecdotal evidence suggests that different combinations may have positive effects on managing blood clot risks and enhancing blood health.
Users report varying experiences and preferences regarding the dosing of folic acid, particularly in the form of methyl folate, for managing blood clot conditions and homocysteine levels. Many users highlight that the methylated form is better absorbed compared to traditional folic acid. For example, one user noted significant improvements after switching to methyl folate, claiming it effectively reduced their homocysteine levels and increased their energy in just a month Read Review. Another user, concerned about thrombophilia, found that the specific form of folate recommended by their doctor helped in thinning the blood effectively Read Review.
In terms of dosage, users suggest taking methyl folate daily, often starting with smaller doses to establish tolerance and observe effects before adjusting. For individuals with specific genetic polymorphisms, it might be particularly crucial to tailor the dosage after consulting with healthcare professionals to optimize levels and support overall health Read Review. Overall, while users emphasize the importance of monitoring personal responses and blood levels, many agree on the benefits of methyl folate for those dealing with blood clot risks.
9
Lowered homocysteine level
27 people found this helpful
Understanding my homocysteine level is crucial as I plan my pregnancy. After discovering it was high, I switched to methyl folate due to allergies with regular folic acid. Within a month, my levels decreased significantly, and I felt more energetic with clearer thoughts—definitely effective.
7.5
Reduced homocysteine levels
2 people found this helpful
Hyperhomocysteinemia can damage blood vessels and lead to blood clots. As half the population struggles to absorb folic acid properly, I tailored my dosage after a test. I decreased my levels significantly in a short time and consulted experts on my progress. Methylfolate is a highly active form and effective.
7.5
Relieved leg pain
1 people found this helpful
I experienced an annoying pain in my legs, feeling as though my blood vessels ached at night. After taking methylfolate, these painful episodes disappeared, although I remain concerned they might return once I stop taking it. Other than that, I have not noticed significant changes in my body.
7.5
Effective for recovery
1 people found this helpful
I purchased this to lower my homocysteine levels after recovering from Covid. It’s an effective formulation, especially since some need B12 alongside it. I find this form safer, particularly for those with mutations in the folate cycle.
9
Improved blood fluidity
I found methylfolate excellent when preparing for pregnancy, especially when combined with niacin. I started with small doses initially. It improved my blood vessel condition and fluidity. During pregnancy, I continued with methylfolate only, and it met my needs despite my genetic issues.
9
Thins blood well
1 people found this helpful
The best form of folic acid is as folates. It is especially beneficial for those with a blood clot condition. I am planning a pregnancy and have thrombophilia; my doctor recommended this particular form as it aids in thinning the blood effectively.
7
Folic acid may reduce thrombus risk
Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study.
We investigated how folic acid supplementation affects blood clots in patients with end-stage kidney disease (ESKD) undergoing hemodialysis. Our research used patient data from the Chang Gung Medical Foundation and compared daily versus weekly folic acid dosages.
Interestingly, patients taking daily folic acid showed a lower rate of arteriovenous access thrombosis compared to those on weekly supplements. However, both groups had similar rates of other serious cardiovascular events, suggesting that while daily supplementation may help with thrombosis, it does not significantly impact overall cardiovascular health.
8
MTHFR mutation linked to thrombosis
Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report.
We examined a unique case of cerebral venous thrombosis in a 14-year-old girl, associated with hyperhomocysteinemia and a rare mutation at the MTHFR locus. The patient displayed symptoms like headaches and nausea, with significantly elevated homocysteine levels.
After receiving a combination of anticoagulation therapy and supplementation with folate, B12, and B6, her condition improved remarkably over a month, reducing intracranial pressure and alleviating symptoms. This case emphasizes the importance of such genetic analysis in similar thrombotic cases.
2
Folate shows no significant benefit
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease.
We investigated how folate and other B-vitamins impact blood clot formation and breakdown in patients with coronary artery disease (CAD). Our large study included nearly 2,000 CAD participants who were given different combinations of folic acid and B-vitamins over 3.8 years as part of the Western Norway B-Vitamin Intervention Trial.
Despite our efforts, we found that folate treatment didn't lead to significant changes in important measures of blood clot functionality, specifically clot lysis time (CLT) and maximum absorbance (Absmax). These factors are critical for understanding how blood clots behave, especially in the context of cardiovascular events like heart attacks.
We observed that higher levels of certain metabolites like homocysteine thiolactone and cysteine were linked to worse outcomes, indicating that while folate did not improve CLT or Absmax, some sulfur-containing compounds might play a significant role in predicting heart risks. Overall, the lack of improvement from B-vitamin therapy sheds light on the complexity of nutrition’s role in heart health.
References
Zhang Y, Ye H, Chen D, Yan G, Li Z, et al. Recurrent syncope after hysteroscopy finally diagnosed as cerebral venous sinus thrombosis: a case report. AJOG Glob Rep. 2025;5:100446. 10.1016/j.xagr.2025.100446
Turcu-Stiolica A, Naidin MS, Halmagean S, Ionescu AM, Pirici I. The Impact of the Dietary Intake of Vitamin B12, Folic Acid, and Vitamin D3 on Homocysteine Levels and the Health-Related Quality of Life of Levodopa-Treated Patients with Parkinson's Disease-A Pilot Study in Romania. Diagnostics (Basel). 2024;14. 10.3390/diagnostics14151609
Zhang M, Shi B, Zhao M. Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report. BMC Neurol. 2023;23:154. 10.1186/s12883-023-03200-y
Lin SS, Fan IW, Chen CY, Su YJ. A nitrous oxide abuser presenting with cerebral venous thrombosis: A case report. Med Int (Lond). 2022;2:20. 10.3892/mi.2022.45
Tu YR, Tu KH, Lee CC, Fan PC, Yen CL, et al. Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study. Nutrients. 2022;14. 10.3390/nu14194162
Chaloulis SK, Tsaousis KT. Cystoid Macular Edema Associated With Venous Stasis in a Patient With Previously Undiagnosed Hyperhomocysteinemia. Cureus. 2021;13:e20782. 10.7759/cureus.20782
Lauretta MP, Melotti RM, Sangermano C, George AM, Badenes R, et al. Homocysteine Plasmatic Concentration in Brain-Injured Neurocritical Care Patients: Systematic Review of Clinical Evidence. J Clin Med. 2022;11. 10.3390/jcm11020394
Meng Q, Li B, Huang N, Wei S, Ren Q, et al. Folic acid targets splenic extramedullary hemopoiesis to attenuate carbon black-induced coagulation-thrombosis potential. J Hazard Mater. 2022;424:127354. 10.1016/j.jhazmat.2021.127354
Cao Y, Yao T, Chen H, Liu H, Li C, et al. The association of serum folate and homocysteine on venous thromboembolism in patients with colorectal cancer: a cross-sectional study. Transl Cancer Res. 2023;12:125. 10.21037/tcr-22-2839
Sikora M, Skrzydlewski P, Perła-Kaján J, Jakubowski H. Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease. PLoS One. 2022;17:e0275956. 10.1371/journal.pone.0275956
Hudson JL, Laura DM, Berrocal AM. CENTRAL RETINAL VEIN OCCLUSION IN 12-YEAR-OLD GIRL WITH METHYLENETETRAHYDROFOLATE REDUCTASE MUTATION: A CASE REPORT AND REVIEW OF THE LITERATURE. Retin Cases Brief Rep. 2023;17:734. 10.1097/ICB.0000000000001283